Darvon & Darvocet Pose Heart Risks

PositiveTips

The U.S. Federal Drug Administration is requesting all manufacturers of the opioid pain reliever propoxyphene (Darvon and Darvocet) to withdraw them from the market due to a high risk of abnormal electrical activity in the heart--even when taken at therapeutic doses. 

PositiveTip: Current users should discontinue these products and consult with their healthcare provider.